Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (‘Ecstasy’)

This publication has 26 references indexed in Scilit:

• 3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans
  Neuroscience & Biobehavioral Reviews, 1999
• Quantitation of N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in human plasma by high-performance liquid chromatography and fluorescence detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1998
• 152 PHARMACOKINETICS OF ECSTASY (MDMA) IN HEALTHY SUBJECTS
  Therapeutic Drug Monitoring, 1997
• Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, “Eve”) and its metabolites in urine by gas chromatography — mass spectrometry and fluorescence polarization immunoassay
  Journal of Chromatography B: Biomedical Sciences and Applications, 1996
• Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion
  Biochemical Pharmacology, 1996
• d-Amphetamine Interaction with Glutathione in Freshly Isolated Rat Hepatocytes
  Chemical Research in Toxicology, 1996
• The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype
  British Journal of Pharmacology, 1995
• Involvement of CYP2D6, CYP3A4, and other cytochrome P-450 isozymes in N-dealkylation reactions
  Journal of Pharmacological and Toxicological Methods, 1994
• Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; “Eve”) in healthy volunteers
  Biological Psychiatry, 1992
• Detection of D,L-Amphetamine, D,L-Methamphetamine, and Illicit Amphetamine Analogs Using Diagnostic Products Corporation's Amphetamine and Methamphetamine Radioimmunoassay*
  Journal of Analytical Toxicology, 1990